CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
EnglishThe adverse effects of drug-drug interactions are costly both in terms of human life and investment (withdrawal of drugs from the market). Inhibition of CYP-mediated (cytochrome P450) drug metabolism by a concomitantly administered second drug is one of the major causes of drug–drug interactions in humans and can lead to serious adverse reactions or toxic side effects. Although less publicised, drug-food interactions can also cause an increase or decrease in the oral drug bioavailability when co-administered, the most well known case being that of grapefruit juice and the short-acting calcium channel blocker, nifedipine. One major limitation of these types of studies is the lack of fast and reliable tests for measuring such phenomena. Here we report the first in vitro characterisation of drug-drug and drug-food interactions of CYP enzymes using an electrochemical platform devised in our group. The use of in vitro data to predict the CYP inhibition by a co-administered drug/food is attractive because of the rapid and simple experimental procedures involved. In terms of drug-drug and drug-food interactions, data will be presented on CYP3A4 inhibition by both strong and weak inhibitors of this enzyme; ketoconazole (anti-fungal), cimetidine (histamine H2-receptor antagonist), grapefruit juice, curcumin (curry spice turmeric) and resveratrol (red wine).
| Titolo: | Drug-drug and food-drug interactions of cytochrome P4503A4 | |
| Autori Riconosciuti: | ||
| Autori: | S.J. Sadeghi; C. Bologna; S. Ferrero; G. Di Nardo; G. Gilardi | |
| Data di pubblicazione: | 2009 | |
| Abstract: | The adverse effects of drug-drug interactions are costly both in terms of human life and investment (withdrawal of drugs from the market). Inhibition of CYP-mediated (cytochrome P450) drug metabolism by a concomitantly administered second drug is one of the major causes of drug–drug interactions in humans and can lead to serious adverse reactions or toxic side effects. Although less publicised, drug-food interactions can also cause an increase or decrease in the oral drug bioavailability when co-administered, the most well known case being that of grapefruit juice and the short-acting calcium channel blocker, nifedipine. One major limitation of these types of studies is the lack of fast and reliable tests for measuring such phenomena. Here we report the first in vitro characterisation of drug-drug and drug-food interactions of CYP enzymes using an electrochemical platform devised in our group. The use of in vitro data to predict the CYP inhibition by a co-administered drug/food is attractive because of the rapid and simple experimental procedures involved. In terms of drug-drug and drug-food interactions, data will be presented on CYP3A4 inhibition by both strong and weak inhibitors of this enzyme; ketoconazole (anti-fungal), cimetidine (histamine H2-receptor antagonist), grapefruit juice, curcumin (curry spice turmeric) and resveratrol (red wine). | |
| Editore: | University of Catania Press | |
| Titolo del libro: | 54th National Congress of the Italian Society of Biochemistry and Molecular Biology | |
| Volume: | 2009 | |
| Pagina iniziale: | 218 | |
| Pagina finale: | 218 | |
| Nome del convegno: | 54th National Congress of the Italian Society of Biochemistry and Molecular Biology | |
| Luogo del convegno: | catania | |
| Anno del convegno: | 23-27 Sept | |
| ISBN: | 9788884538208 | |
| Parole Chiave: | Human cytochrome P450; Drug-drug interactions; Electrochemistry; glassy carbon electrode | |
| Appare nelle tipologie: | 04A-Conference paper in volume |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| SIB-2009-sadeghi.pdf | MATERIALE NON BIBLIOGRAFICO | Accesso aperto | Open Access Visualizza/Apri |
Copyright © 2022